Adelaide Research & Scholarship: Search

Search

Results 1-10 of 25 (Search time: 0.002 seconds).

previous
1
2
3
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2002	Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures	Csimma, C.; Genant, H.; Valentin-Opran, A.; Amit, Y.; Arbel, R.; Aro, H.; Atar, D.; Bishay, M.; Borner, M.; Chiron, P.; Choong, P.; Cinats, J.; Courtenay, B.; Feibel, R.; Geulette, B.; Gravel, C.; Haas, N.; Raschke, M.; Hammacher, E.; van der Velde, D.; et al.
	2004	Interferon-α-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia	Mollee, P.; Arthur, C.; Hughes, T.; Januszewicz, H.; Grigg, A.; Bradstock, K.; Wolf, M.; Gibson, J.; Schwarer, A.; Spencer, A.; Browett, P.; Hawkins, T.; Seldon, M.; Herrmann, R.; Watson, A.; Seymour, J.; Martin, N.; Shina, S.; Low, C.; Wright, S.; et al.
	2001	Integration of cytogenetic landmarks into the draft sequence of the human genome	Cheung, V.; Nowak, N.; Jang, W.; Kirsch, I.; Zhao, S.; Chen, X.; Furey, T.; Kim, U.; Kuo, W.; Olivier, M.; Conroy, J.; Kasprzyk, A.; Massa, H.; Yonescu, R.; Sait, S.; Thoreen, C.; Snijders, A.; Lemyre, E.; Bailey, J.; Bruzel, A.; et al.
	2006	Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia	Druker, B.; Guilhot, F.; O'Brien, S.; Gathmann, I.; Kantarjian, H.; Gattermann, N.; Deininger, M.; Silver, R.; Goldman, J.; Stone, R.; Cervantes, F.; Hochhaus, A.; Powell, B.; Gabrilove, J.; Rousselot, P.; Reiffers, J.; Cornelissen, J.; Hughes, T.; Agis, H.; Fischer, T.; et al.
	2002	Repair of Groin Hernia With Synthetic Mesh: Meta-Analysis of Randomized Controlled Trials	Grant, A.; Go, P.; Fingerhut, A.; Kingsnorth, A.; Merello, J.; O'Dwyer, P.; Payne, J.; McCormack, K.; Ross, S.; Scott, N.; Vale, L.; Aitola, P.; Anderberg, B.; Barkun, J.; Barth Jnr, R.; Bay-Nielsen, M.; Bittner, R.; Bringman, S.; Callesen, T.; Castoro, C.; et al.
	2002	Considerations for the safe prescribing and use of COX-2-specific inhibitors	Barraclough, D.; Bertouch, J.; Brooks, P.; Brown, M.; Cleland, L.; Clemens, L.; Crowley, S.; Day, R.; DeJager, J.; Edmonds, J.; Fletcher, P.; Franks, G.; Harris, D.; Horowitz, J.; Johnston, M.; Kerr, S.; Littlejohn, G.; MacDonald, G.; McColl, G.; Sambrook, P.; et al.
	2009	Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes	Galluzzi, L.; Aaronson, S.A.; Abrams, J.; Alnemri, E.S.; Andrews, D.W.; Baehrecke, E.H.; Bazan, N.G.; Blagosklonny, M.V.; Blomgren, K.; Borner, C.; Bredesen, D.E.; Brenner, C.; Castedo, M.; Cidlowski, J.A.; Ciechanover, A.; Cohen, G.M.; De Laurenzi, V.; De Maria, R.; Deshmukh, M.; Dynlacht, B.D.; et al.
	2008	Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia	le Coutre, P.; Ottmann, O.; Giles, F.; Kim, D.; Cortes, J.; Gattermann, N.; Apperley, J.; Larson, R.; Abruzzese, E.; O'Brien, S.; Kuliczkowski, K.; Hochhaus, A.; Mahon, F.; Saglio, G.; Gobbi, M.; Kwong, Y.; Baccarani, M.; Hughes, T.; Martinelli, G.; Radich, J.; et al.
	2008	Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group	Ryan, G.; Martinelli, G.; Kuper-Hommel, M.; Tsang, R.; Pruneri, G.; Yuen, K.; Roos, D.; Lennard, A.; Devizzi, L.; Crabb, S.; Hossfeld, D.; Pratt, G.; Dell'Olio, M.; Choo, S.; Bociek, R.; Radford, J.; Lade, S.; Gianni, A.; Zucca, E.; Cavalli, F.; et al.
	2002	Open mesh versus non-mesh repair of groin hernia meta-analysis of randomized trials leased on individual patient data	Fingerhut, A.; Go, P.; Grant, A.; Kingsnorth, A.; Merello, J.; O'Dwyer, P.; Payne, J.; McCormack, K.; Ross, S.; Scott, N.; Vale, L.; Aitola, P.; Anderberg, B.; Arvidsson, D.; Barkun, J.; Barth Jnr, R.; Bay-Nielsen, M.; Beets, G.; Bittner, R.; Bringman, S.; et al.